Cargando…
New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine
Cariprazine is a recently developed antipsychotic drug with a partial agonism for the D(2) and D(3) receptors. It shows a tenfold greater affinity for the D(3) receptor. In clinical trials, its therapeutic effect has been tested in patients with an acute exacerbation of schizophrenia and in patients...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636086/ https://www.ncbi.nlm.nih.gov/pubmed/26586950 http://dx.doi.org/10.2147/TCRM.S64915 |